GLOBUS MEDICAL INC

GMED

GLOBUS MEDICAL INC

GMED

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-05Shares Purchased (TTM):0Shares Sold (TTM):152,636

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:102,465,004Shares Outstanding:135,364,000Institutional Ownership Pct.:75.70%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Common Class A	-	0	0	-	-	113	0	-	-	-	-	-
Common Class B	-	0	0	-	-	22	0	-	-	-	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	508	561	526	372	229	461	784	623	410	354	467	280
Marketable Securities Current	87	69	31	19	-	-	106	72	83	80	50	189
Accounts Receivable Net Current	692	686	679	619	612	535	558	588	612	534	503	494
Inventory Net	811	773	759	772	772	664	659	718	770	816	848	905
Prepaid Expense And Other Assets Current	70	60	65	74	68	47	50	51	46	43	45	48
Income Taxes Receivable	47	49	65	69	49	3	21	5	2	0	2	2
Assets Current	2,216	2,198	2,126	1,924	1,730	1,710	2,177	2,057	1,924	1,829	1,915	1,917
Property Plant And Equipment Net	534	557	564	578	588	556	562	568	572	579	587	607
Operating Lease Right Of Use Asset	59	62	64	59	62	48	50	53	54	56	60	95
Marketable Securities Noncurrent	245	169	72	17	-	-	66	12	28	51	75	276
Intangible Assets Net Excluding Goodwill	693	721	745	774	796	772	795	843	867	888	925	1,262
Goodwill	1,438	1,439	1,435	1,434	1,435	1,433	1,432	1,432	1,454	1,451	1,435	1,122
Other Assets Noncurrent	79	79	79	77	75	75	75	77	78	78	79	69
Deferred Income Tax Assets Net	225	215	218	232	276	117	94	45	18	11	11	7
Assets	5,488	5,440	5,303	5,096	4,961	4,711	5,252	5,086	4,994	4,944	5,086	5,356
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	107	104	99	87	87	73	75	58	67	50	57	87
Accrued Liabilities Current	301	313	334	326	282	238	261	255	216	210	240	222
Operating Lease Liability Current	14	15	15	14	13	11	10	11	11	12	12	13
Accrued Income Taxes Current	6	3	4	1	-	13	11	4	11	43	4	34
Deferred Revenue Current	-	-	-	18	24	17	22	21	20	17	18	18
Payables To Broker Dealers And Clearing Organizati…	-	-	-	-	-	-	-	-	-	0	-	-
Senior Notes Current	-	-	0	-	-	-	443	437	430	424	-	-
Contract With Customer Liability Current	28	26	28	-	-	-	22	-	-	-	-	-
Liabilities Current	479	482	498	466	425	385	856	818	794	786	392	429
Operating Lease Liability Noncurrent	97	100	104	105	108	82	84	86	88	90	91	100
Convertible Debt Noncurrent	-	-	-	-	-	-	-	-	-	-	417	410
Deferred Income Tax Liabilities Net	-	-	-	23	24	47	24	7	27	40	84	132
Deferred Income Taxes And Other Tax Liabilities No…	42	25	24	-	-	-	24	-	-	-	-	-
Other Liabilities Noncurrent	19	21	21	25	22	25	22	23	25	24	25	22
Liabilities	720	707	730	697	665	623	1,074	1,017	1,017	1,021	1,088	1,169
Stockholders Equity
Additional Paid In Capital	3,230	3,206	3,170	3,095	3,072	3,054	3,031	2,950	2,914	2,886	2,871	2,858
Accumulated Other Comprehensive Income Loss Net Of…	11	14	15	11	10	-2	-7	-7	-12	-11	-10	-19
Retained Earnings Accumulated Deficit	1,527	1,512	1,388	1,292	1,214	1,036	1,153	1,126	1,074	1,047	1,137	1,348
Stockholders Equity	4,769	4,732	4,573	4,399	4,296	4,088	4,177	4,069	3,976	3,922	3,998	4,187
Liabilities And Stockholders Equity	5,488	5,440	5,303	5,096	4,961	4,711	5,252	5,086	4,994	4,944	5,086	5,356
Accumulated Depreciation Depletion And Amortizatio…	-	748	705	647	602	572	546	506	480	447	426	388
Allowance For Doubtful Accounts Receivable Current	44	41	33	27	27	8	16	24	19	12	9	9
Property Plant And Equipm…
Common Stock Shares Authorized	775	775	775	775	775	775	775	775	775	775	775	775

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.75%	1.39%	-10.09%	-	-	-	-	-	-	-	-	-
2025	-18.33%	-19.13%	-24.81%	13.32%	3.01%	15.20%	47.53%	43.27%	49.93%	-6.12%	3.67%	-16.59%
2024	30.67%	33.35%	39.97%	5.29%	2.26%	5.97%	13.27%	10.56%	22.84%	-15.55%	-13.71%	-33.64%
2023	-	-	-	-	-	-	-0.39%	15.37%	16.37%	-6.55%	-6.05%	17.67%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.62	4.56	4.26	4.13	4.07	4.45	2.54	2.51	2.42	2.33	4.88	4.47
Quick Ratio	2.78	2.83	2.61	2.31	2.09	2.60	1.72	1.57	1.39	1.23	2.61	2.25
Working Capital	1.74B	1.72B	1.63B	1.46B	1.31B	1.33B	1.32B	1.24B	1.13B	1.04B	1.52B	1.49B
Leverage & Debt
Debt to Equity	0.15	0.15	0.16	0.16	0.15	0.15	0.26	0.25	0.26	0.26	0.27	0.28
Interest Coverage TTM	45.80	70.32	125.31	79.83	71.01	45.49	28.53	15.27	4.63	4.10	5.26	6.32
Debt Ratio	0.13	0.13	0.14	0.14	0.13	0.13	0.20	0.20	0.20	0.21	0.21	0.22
Efficiency & Turnover
Asset Turnover TTM	0.60	0.61	0.56	0.54	0.53	0.52	0.49	0.47	0.62	0.54	0.44	0.33
Days Sales Outstanding TTM	75.66	71.90	76.79	79.54	85.00	77.73	76.85	79.68	69.52	72.78	83.37	104.23
Receivables Turnover TTM	4.82	5.08	4.75	4.59	4.29	4.70	4.75	4.58	5.25	5.01	4.38	3.50
Per Share Metrics
Diluted EPS TTM	3.90	4.25	3.92	3.13	2.61	1.33	0.75	0.66	0.30	0.49	1.07	1.37
Free Cash Flow Per Share TTM	5.59	4.51	4.35	4.31	3.90	3.82	2.99	2.17	1.19	1.12	1.46	1.14
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	68.55%	67.86%	67.41%	65.34%	62.76%	60.59%	58.90%	58.14%	59.65%	62.14%	65.05%	71.19%
Operating Profit Margin TTM	20.34%	17.20%	16.33%	13.39%	10.72%	10.16%	6.59%	4.67%	3.05%	4.46%	8.49%	14.44%
Net Profit Margin TTM	17.03%	18.92%	18.30%	15.30%	13.58%	7.39%	4.09%	3.69%	1.82%	3.51%	7.83%	12.87%
Growth Metrics
Net Revenue Growth (1Y)	19.74%	23.49%	16.65%	11.75%	17.43%	32.26%	60.62%	102.10%	103.89%	77.59%	53.34%	22.84%
Net Income Growth (1Y)	50.13%	216.18%	422.28%	363.08%	776.83%	178.51%	-16.19%	-42.04%	-80.09%	-66.89%	-35.39%	1.73%
EPS Growth (1Y)	50.30%	219.43%	424.26%	366.91%	776.76%	175.66%	-30.17%	-51.48%	-85.22%	-75.47%	-42.60%	-10.71%
Valuation Metrics
P/E TTM	19.93	19.88	21.95	18.18	22.37	53.95	109.01	106.02	227.65	108.97	49.05	35.70
P/B TTM	2.24	2.46	2.58	1.75	1.86	2.45	2.69	2.38	2.33	1.85	1.51	1.35
P/S TTM	3.39	3.76	4.02	2.78	3.04	3.99	4.46	3.91	4.14	3.82	3.84	4.60
Market Cap	10.67B	11.66B	11.81B	7.70B	7.98B	10.01B	11.23B	9.70B	9.26B	7.26B	6.03B	5.64B
Enterprise Value	10.16B	11.10B	11.28B	7.33B	7.75B	9.55B	10.44B	9.08B	8.85B	6.91B	5.98B	5.77B
Calculated Values
Free Cash Flow TTM	755.59M	610.32M	588.77M	579.61M	527.43M	522.59M	405.21M	293.77M	161.02M	151.72M	165.23M	129.07M
Net Debt	-507.75M	-560.95M	-526.16M	-371.77M	-229.45M	-461.27M	-784.44M	-622.77M	-410.42M	-354.06M	-49.89M	130.10M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-05Sale

Owner: Davidar, David D

Title: -

Shares: 25,000

Price/Share: $80.76

Value: $2,019,000.00

Shares Owned: 510,175

Relationship: Director

Ownership: Direct

2026-02-25Sale

Owner: Huller, Kelly

Title: EVP, GC, Corporate Secretary

Shares: 20,000

Price/Share: $94.50

Value: $1,890,000.00

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-02-12Sale

Owner: Huller, Kelly

Title: EVP, GC, Corporate Secretary

Shares: 10,000

Price/Share: $87.67

Value: $876,700.00

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-01-08Sale

Owner: Norwalk, Leslie V

Title: -

Shares: 2,000

Price/Share: $101.10

Value: $202,200.00

Shares Owned: 10,419

Relationship: Director

Ownership: Direct

2026-01-08Sale

Owner: Kline, Kyle

Title: Senior Vice President, CFO

Shares: 3,594

Price/Share: $101.10

Value: $363,353.40

Shares Owned: -

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-05	Davidar, David D	Director	-	Direct	Sale	25,000	80.76	$2,019,000.00	510,175	4
2026-02-25	Huller, Kelly	Officer	EVP, GC, Corporate Secretary	Direct	Sale	20,000	94.50	$1,890,000.00	0	4
2026-02-12	Huller, Kelly	Officer	EVP, GC, Corporate Secretary	Direct	Sale	10,000	87.67	$876,700.00	0	4
2026-01-08	Norwalk, Leslie V	Director	-	Direct	Sale	2,000	101.10	$202,200.00	10,419	4
2026-01-08	Kline, Kyle	Officer	Senior Vice President, CFO	Direct	Sale	3,594	101.10	$363,353.40	0	4
2025-12-12	Norwalk, Leslie V	Director	-	Direct	Sale	4,000	88.85	$355,400.00	12,419	4
2025-12-01	Kline, Kyle	Officer	Senior Vice President, CFO	Direct	Sale	18,542	90.00	$1,668,780.00	0	4
2025-11-25	Huller, Kelly	Officer	SVP, GC, Corporate Secretary	Direct	Sale	7,500	90.00	$675,000.00	0	4
2025-11-12	Davidar, David D	Director	-	Direct	Sale	25,000	86.00	$2,150,000.00	516,275	4
2025-11-11	Zarrilli, Stephen T	Director	-	Direct	Sale	25,000	84.29	$2,107,250.00	0	4
2025-11-10	Rhoads, Ann D	Director	-	Direct	Sale	2,000	85.00	$170,000.00	15,384	4
2025-09-15	Rhoads, Ann D	Director	-	Direct	Sale	10,000	58.46	$584,600.00	25,384	4
2025-02-28	Rhoads, Ann D	Director	-	Direct	Sale	7,500	78.68	$590,100.00	35,384	4
2025-01-10	Pfeil, Keith W	Officer	COO, CFO	Direct	Sale	14,167	88.67	$1,256,187.89	0	4
2024-12-02	Huller, Kelly	Officer	SVP, GC, Corporate Secretary	Direct	Sale	2,500	87.00	$217,500.00	0	4
2024-11-22	Davidar, David D	Director	-	Direct	Sale	6,766	85.00	$575,110.00	516,275	4
2024-11-22	Lemaitre, Dan	Director	-	Direct	Sale	1,097	85.02	$93,266.94	0	4
2024-11-21	Scavilla, Daniel T	Director,Officer	President, CEO	Direct	Sale	130,000	85.00	$11,050,000.00	0	4
2024-11-06	Huller, Kelly	Officer	SVP, GC, Corporate Secretary	Direct	Sale	5,000	81.01	$405,050.00	0	4
2024-11-06	Scavilla, Daniel T	Director,Officer	President, CEO	Direct	Sale	60,000	80.02	$4,801,200.00	0	4
2024-10-16	Davidar, David D	Director	-	Direct	Sale	30,000	75.04	$2,251,200.00	536,275	4
2024-10-16	Huller, Kelly	Officer	SVP, GC, Corporate Secretary	Direct	Sale	7,500	75.02	$562,650.00	-	4
2024-09-13	Rhoads, Ann D	Director	-	Direct	Sale	15,000	70.36	$1,055,400.00	42,884	4
2024-09-13	Davidar, David D	Director	-	Direct	Sale	25,000	70.46	$1,761,500.00	566,275	4
2024-07-11	Norwalk, Leslie V	Director	-	Direct	Sale	1,000	70.00	$70,000.00	16,419	4
2024-05-10	Lemaitre, Dan	Director	-	Direct	Sale	63,300	64.61	$4,089,813.00	0	4
2024-05-08	Davidar, David D	Director	-	Direct	Sale	20,000	65.00	$1,300,000.00	566,275	4
2024-03-15	Norwalk, Leslie V	Director	-	Direct	Sale	10,590	51.99	$550,574.10	17,419	4
2024-03-01	Huller, Kelly	Officer	SVP, GC, Corporate Secretary	Direct	Sale	7,500	54.16	$406,200.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

75.70%

Inst. Shares: 102,465,004

Shares Outstanding: 135,364,000

2025-12-31

78.74%

Inst. Shares: 106,467,091

Shares Outstanding: 135,215,000

2025-09-30

81.61%

Inst. Shares: 109,764,039

Shares Outstanding: 134,502,000

2025-06-30

79.49%

Inst. Shares: 107,468,888

Shares Outstanding: 135,205,000

2025-03-31

73.77%

Inst. Shares: 100,885,238

Shares Outstanding: 136,757,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	102,465,004	135,364,000	75.70%
2025-12-31	106,467,091	135,215,000	78.74%
2025-09-30	109,764,039	134,502,000	81.61%
2025-06-30	107,468,888	135,205,000	79.49%
2025-03-31	100,885,238	136,757,000	73.77%
2024-12-31	99,554,588	135,726,000	73.35%
2024-09-30	94,964,400	135,615,000	70.02%
2024-06-30	101,584,893	135,195,000	75.14%
2024-03-31	100,613,049	135,358,000	74.33%
2023-12-31	96,717,892	113,087,000	85.53%
2023-09-30	98,769,623	113,537,000	86.99%
2023-06-30	73,783,309	100,373,000	73.51%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

GLOBUS MEDICAL INC (GMED) — SEC Financial Statements & Analysis

GLOBUS MEDICAL INC (GMED) is a surgical & medical instruments & apparatus company, incorporated in DE. GLOBUS MEDICAL INC trades on NYSE as: GMED. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GLOBUS MEDICAL INC reported a 19.74% year-over-year revenue growth, a Gross Profit Margin of 68.55% (TTM), a Debt-to-Equity ratio of 0.15x, a Price-to-Sales (P/S) ratio of 3.39x (TTM), a Price-to-Book (P/B) ratio of 2.24x (TTM), at a market cap of $10.67B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 19.74%
Gross Profit Margin TTM: 68.55%
Debt To Equity: 0.15x
P/S TTM: 3.39x
P/B TTM: 2.24x
Market Cap: $10.67B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GLOBUS MEDICAL INC in?

GLOBUS MEDICAL INC (GMED) operates in the Surgical & Medical Instruments & Apparatus industry.

What is GMED's market cap?

GLOBUS MEDICAL INC (GMED) has a market capitalization of $10.67B as of 2026-06-30.

What is GMED's P/E ratio?

GLOBUS MEDICAL INC (GMED)'s trailing twelve month P/E ratio is 19.93x as of 2026-06-30.

What exchange does GMED trade on?

GLOBUS MEDICAL INC (GMED) trades on the NYSE.

Where is GLOBUS MEDICAL INC incorporated?

GLOBUS MEDICAL INC is incorporated in DE.